D-JNKI-1: Phase III started

Auris began the double-blind, placebo-controlled, international Phase III ASSENT trial to

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE